EQT Corporation/ US26884L1098 /
2024-05-16 6:31:07 PM | Chg. +0.25 | Volume | Bid2024-05-16 | Ask2024-05-16 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
41.18USD | +0.61% | 3.15 mill. Turnover: 110.86 mill. |
41.17Bid Size: 700 | 41.18Ask Size: 400 | 18.3 bill.USD | 1.47% | 9.09 |
GlobeNewswire
05-13
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reneo Pharm...
GlobeNewswire
05-06
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ALLETE, Inc...
GlobeNewswire
05-06
Is Perficient's $76 Per Share Sale Price Fair? Johnson Fistel, LLP Investigates Deal Terms
GlobeNewswire
05-06
PRFT Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Perficient to EQT A...
GlobeNewswire
04-18
GA Drilling Announces First Close of $15M to Accelerate the Delivery of Deep Geothermal Energy
GlobeNewswire
03-21
Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nou...
GlobeNewswire
03-21
ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookb...
GlobeNewswire
03-20
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Publi...
GlobeNewswire
03-20
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Publi...
GlobeNewswire
03-20
FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director
GlobeNewswire
03-15
STOCKHOLDER ALERT: The M&A Class Action Launches Investigation of the Merger – EVRI, ANSS, ETRN, VIV...